المؤلفون: Inge Marie Svane, Santosh M. Nair, Igor Puzanov, Caroline Robert, Jessica Cecile Hassel, Shahneen Sandhu, Anita Vedel Christiansen, Kath Lowery, Kristine Pemberton, Mohammad Al Hajj, Scott J. Diede, Eva Ehrnrooth, Alexander M. Eggermont

المصدر: Journal of Clinical Oncology. 40:TPS9589-TPS9589

مصطلحات موضوعية: Cancer Research, Oncology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::4323639b2a1d3c1728923bdf5ece663dTest
https://doi.org/10.1200/jco.2022.40.16_suppl.tps9589Test

المؤلفون: Frank Trudo, Gary T. Ferguson, Tor Skärby, Kristina Sandin, Mike Greenwood, Carin Jorup, Donald P. Tashkin, Kristine Pemberton

المصدر: Respiratory medicine. 132

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Budesonide, Adult, Male, medicine.medical_specialty, Exacerbation, Vital Capacity, Severity of Illness Index, 03 medical and health sciences, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Double-Blind Method, Internal medicine, Forced Expiratory Volume, Formoterol Fumarate, Administration, Inhalation, medicine, Budesonide, Formoterol Fumarate Drug Combination, Humans, 030212 general & internal medicine, Metered Dose Inhalers, Glucocorticoids, Aged, Proportional Hazards Models, Aged, 80 and over, COPD, business.industry, Inhaler, Dry Powder Inhalers, respiratory system, Middle Aged, medicine.disease, Metered-dose inhaler, Dry-powder inhaler, respiratory tract diseases, Bronchodilator Agents, Treatment Outcome, 030228 respiratory system, Budesonide/formoterol, Disease Progression, Female, Formoterol, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::039694d1fb5f9f35ac44e5c0dc80fbe7Test
https://pubmed.ncbi.nlm.nih.gov/29229103Test

المؤلفون: Stefan Ivanov, Peter J. Barnes, Eric D. Bateman, Nanshan Zhong, J. Mark FitzGerald, Gun Almqvist, Helen K. Reddel, Christina Keen, Kristine Pemberton, Paul M. O'Byrne, Carin Jorup

المساهمون: Department of Medicine, Faculty of Health Sciences

المصدر: O'Byrne, P, Fitzgerald, J M, Zhong, N S, Bateman, E D, Barnes, P J, Keen, C, Almqvist, G, Pemberton, K, Jorup, C, Ivanov, S & Reddel, H K 2017, ' The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given 'as needed' in mild asthma: study protocols for two randomised controlled trials. ', Trials, vol. 18, no. 1, pp. 12-25 . https://doi.org/10.1186/s13063-016-1731-4Test
Trials

مصطلحات موضوعية: Budesonide, As-needed, PERSISTENT ASTHMA, Prn, Medicine (miscellaneous), Research & Experimental Medicine, INHALED CORTICOSTEROIDS, Study Protocol, 0302 clinical medicine, Clinical Protocols, RELIEVER THERAPY, Formoterol Fumarate, Pharmacology (medical), 030212 general & internal medicine, Rescue inhaler, Randomized Controlled Trials as Topic, FORMOTEROL, SYGMA, Medicine, Research & Experimental, Life Sciences & Biomedicine, medicine.drug, medicine.medical_specialty, Terbutaline, Mild asthma, Placebo, 1102 Cardiovascular Medicine And Haematology, Exacerbations, INTERMITTENT, 03 medical and health sciences, Double-Blind Method, General & Internal Medicine, Internal medicine, Asthma control, medicine, Humans, COMBINATION, Budesonide/formoterol, Asthma, Science & Technology, business.industry, 1103 Clinical Sciences, medicine.disease, PREVENTION, respiratory tract diseases, Patient recruitment, Cardiovascular System & Hematology, Clinical Trials, Phase III as Topic, 030228 respiratory system, CLINICAL-PRACTICE, Sample Size, Physical therapy, Formoterol, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d3466afaa55bfc3a4cb3b796c823b40Test
https://hdl.handle.net/11427/24047Test

المؤلفون: Celestia S. Higano, F. E. Nathan, Kurt Miller, Joel B. Nelson, Martin E. Gleave, Stuart McIntosh, Karim Fizazi, Judd W. Moul, Kristine Pemberton, Thomas Morris

المصدر: Journal of Clinical Oncology. 31:1740-1747

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Zibotentan, Nausea, business.industry, Hazard ratio, Placebo-controlled study, Peripheral edema, Urology, medicine.disease, Placebo, Prostate cancer, chemistry.chemical_compound, Docetaxel, chemistry, Internal medicine, medicine, medicine.symptom, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::0f96b7a0eac08dd70fa776046fdc257eTest
https://doi.org/10.1200/jco.2012.46.4149Test

المؤلفون: Celestia S. Higano, Judd W. Moul, Martin E. Gleave, Kurt Miller, Karim Fizazi, Thomas Morris, Hideyuki Akaza, Stuart McIntosh, Joel B. Nelson, Kristine Pemberton

المصدر: Cancer. 118:5709-5718

مصطلحات موضوعية: Male, Cancer Research, medicine.medical_specialty, Pyrrolidines, Survival, Endothelin A Receptor Antagonists, Urology, Placebo-controlled study, Antineoplastic Agents, Bone Neoplasms, Placebo, Disease-Free Survival, law.invention, Placebos, Prostate cancer, chemistry.chemical_compound, Randomized controlled trial, law, medicine, Clinical endpoint, Humans, Endothelin-1, Zibotentan, business.industry, Hazard ratio, Prostatic Neoplasms, Common Terminology Criteria for Adverse Events, medicine.disease, Surgery, Treatment Outcome, Oncology, chemistry, business, Orchiectomy

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be2f7e47580e44d7ba93ec08723d1e31Test
https://doi.org/10.1002/cncr.27674Test

المؤلفون: Kevin Carroll, Stuart Ellis, Kristine Pemberton

المصدر: Contemporary Clinical Trials. 29:456-465

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Time Factors, Treatment outcome, Antineoplastic Agents, Neoplasms, Internal medicine, Humans, Medicine, Pharmacology (medical), Fraction (mathematics), Duration (project management), Clinical Trials as Topic, Cytotoxins, business.industry, Treatment difference, Data interpretation, Gefitinib, General Medicine, Models, Theoretical, Prognosis, Clinical trial, Treatment Outcome, Data Interpretation, Statistical, Quinazolines, Response Duration, business, Response probability

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13e2477ac5882f03f3f65c3cf4c088b4Test
https://doi.org/10.1016/j.cct.2007.10.008Test

المؤلفون: Eduard Vrdoljak, Inci Erensoy, Rabab Gaafar, Tanja Cufer, Kristine Pemberton

المصدر: Anti-Cancer Drugs. 17:401-409

مصطلحات موضوعية: Adult, Male, Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Docetaxel, law.invention, Gefitinib, Randomized controlled trial, law, Carcinoma, Non-Small-Cell Lung, Internal medicine, medicine, Humans, Pharmacology (medical), Epidermal growth factor receptor, Adverse effect, Lung cancer, neoplasms, Aged, Neoplasm Staging, Aged, 80 and over, Pharmacology, gefitinib, docetaxel, advanced non-small-cell lung cancer, biology, business.industry, Middle Aged, medicine.disease, Antineoplastic Agents, Phytogenic, Survival Analysis, Chemotherapy regimen, respiratory tract diseases, Tolerability, Quinazolines, biology.protein, Female, Taxoids, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39d039d26791fa2b050a535be0c1d54cTest
https://doi.org/10.1097/01.cad.0000203381.99490.abTest

المؤلفون: Stuart McIntosh, Joel B. Nelson, Kurt Miller, Celestia S. Higano, F. E. Nathan, Kristine Pemberton, Thomas Morris, Martin E. Gleave, Karim Fizazi, Judd W. Moul

المصدر: Prostate cancer and prostatic diseases. 16(2)

مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Pyrrolidines, Urology, Placebo-controlled study, Administration, Oral, Antineoplastic Agents, Kaplan-Meier Estimate, Adenocarcinoma, Placebo, Drug Administration Schedule, law.invention, chemistry.chemical_compound, Randomized controlled trial, Double-Blind Method, law, medicine, Edema, Humans, Aged, Proportional Hazards Models, Aged, 80 and over, Zibotentan, business.industry, Standard treatment, Hazard ratio, Middle Aged, Interim analysis, Clinical trial, Prostatic Neoplasms, Castration-Resistant, Treatment Outcome, Oncology, chemistry, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1661aad8567173dd3c1e1cc27a7098cfTest
https://pubmed.ncbi.nlm.nih.gov/23381694Test

المؤلفون: Antonella Savarese, E Mari, Pauline Wimberger, Francesco Cognetti, Giovanni Scambia, Klaus Baumann, Nicoletta Colombo, Kristine Pemberton, F. E. Nathan, P. Harter, Anna Bagnato, Stuart McIntosh, Roberto Sorio, Jalid Sehouli

المساهمون: Cognetti, F, Bagnato, A, Colombo, N, Savarese, A, Scambia, G, Sehouli, J, Wimberger, P, Sorio, R, Harter, P, Mari, E, Mcintosh, S, Nathan, F, Pemberton, K, Baumann, K

المصدر: Gynecologic oncology. 130(1)

مصطلحات موضوعية: Oncology, Pyrrolidines, medicine.medical_treatment, Medizin, Carcinoma, Ovarian Epithelial, ZD4054, Pyrrolidine, Carboplatin, Placebos, chemistry.chemical_compound, Antineoplastic Combined Chemotherapy Protocols, Neoplasms, Glandular and Epithelial, carboplatin/paclitaxel, Cancer, zibotentan, Ovarian Neoplasms, Zibotentan, Obstetrics and Gynecology, Middle Aged, Paclitaxel, Tolerability, Ovarian, Female, Human, Adult, medicine.medical_specialty, Placebo, Disease-Free Survival, Drug Administration Schedule, Young Adult, Double-Blind Method, Internal medicine, medicine, Humans, Aged, Chemotherapy, Antineoplastic Combined Chemotherapy Protocol, business.industry, Ovarian Neoplasm, medicine.disease, Surgery, Settore MED/40 - GINECOLOGIA E OSTETRICIA, chemistry, Advanced, Ovarian cancer, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dd647d4e8e411e2e422e120a87867b1Test
https://pubmed.ncbi.nlm.nih.gov/23234805Test

المؤلفون: Christos Chouaid, Thomas Morris, Kristine Pemberton, F. E. Nathan

المساهمون: Epidémiologie des maladies infectieuses et modélisation (ESIM), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), AstraZeneca

المصدر: Cancer Chemotherapy and Pharmacology
Cancer Chemotherapy and Pharmacology, Springer Verlag, 2011, 67 (5), pp.1203-8. ⟨10.1007/s00280-010-1538-z⟩
Cancer Chemotherapy and Pharmacology, Springer Verlag, 2010, 67 (5), pp.1203-1208. ⟨10.1007/s00280-010-1538-z⟩
Cancer Chemotherapy and Pharmacology, 2011, 67 (5), pp.1203-8. ⟨10.1007/s00280-010-1538-z⟩

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Guanine, Lung Neoplasms, Pyrrolidines, Randomization, Pemetrexed, Toxicology, NSCLC, Endothelin, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Double-Blind Method, Glutamates, Zibotentan, Carcinoma, Non-Small-Cell Lung, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Pharmacology (medical), 030212 general & internal medicine, Neoplasm Metastasis, Lung cancer, Survival rate, ComputingMilieux_MISCELLANEOUS, Cancer, Pharmacology, business.industry, medicine.disease, 3. Good health, Surgery, Survival Rate, Clinical trial, Tolerability, chemistry, 030220 oncology & carcinogenesis, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c33d41804d7d57e2e805c34ff8a4419Test
https://hal.sorbonne-universite.fr/hal-00596809Test